CX CEMEX, S.A.B. de C.V.
CEMEX, S.A.B. de C.V., together with its subsidiaries, engages in the production, marketing, distribution, and sale of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services worldwide. It offers gray ordinary portland, white portland, and blended cement products; masonry or mortar products; standard ready-mix, architectural and decorative, rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial, and other concrete products; aggregate products, including crushed stone and manufactured sand, gravel, sand, and recycled concrete; and vertua products. The company also provides urbanization solutions for construction chemicals, mortars, concrete products, and asphalt businesses, as well as municipal and industrial waste management solutions; and construction, demolition, and excavation waste solutions. CEMEX, S.A.B. de C.V. was founded in 1906 and is based in San Pedro Garza García, Mexico.…
Industry Peers
Building MaterialsKey Statistics
About CEMEX (NYSE: CX)
›
CEMEX (NYSE: CX) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Building Materials industry, part of the Basic Materials sector, and reports about 38,023 employees.
The shares were at 9.420 USD on 19 November 2026, up 4.3% over 52 weeks. Its 52-week range is 8.960 USD to 13.67 USD: the price is 31.1% below the high and 5.1% above the low.
At a market capitalisation of 13.59B USD, it trades at 58.9 times trailing earnings and 10.5 times forward earnings. The median trailing P/E of its 19 largest Building Materials peers is 17.1, a premium of 245% for CX. It pays a dividend yielding 1.27% (it pays out 68% of its earnings), against a median of 1.64% among the dividend payers in that peer group.
CEMEX reports return on equity of 7.2%, an operating margin of 13.3% and revenue up 8.1% year over year.
Its debt exceeds its cash by 7.03B USD, a debt-to-equity ratio of 0.51. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 15 analysts cover the stock, with an average rating of Buy; their mean price target of 14.77 USD is 56.8% above the current price. The next earnings report is expected on 18 February 2027.